Regulated necrosis at the crossroads of liver inflammation and cancer development.
2/5 보강
TL;DR
The key regulatory molecules that govern regulated necrosis pathways are discussed and the current understanding of the involvement of necroptosis, pyroptosis and ferroptosis in liver injury in preclinical murine models of acute and chronic liver disease and liver cancer development is summarized.
OpenAlex 토픽 ·
Inflammasome and immune disorders
Ferroptosis and cancer prognosis
Liver Diseases and Immunity
The key regulatory molecules that govern regulated necrosis pathways are discussed and the current understanding of the involvement of necroptosis, pyroptosis and ferroptosis in liver injury in precli
APA
Mihael Vucur, Vangelis Kondylis, et al. (2026). Regulated necrosis at the crossroads of liver inflammation and cancer development.. Nature reviews. Gastroenterology & hepatology, 23(4), 331-354. https://doi.org/10.1038/s41575-025-01147-8
MLA
Mihael Vucur, et al.. "Regulated necrosis at the crossroads of liver inflammation and cancer development.." Nature reviews. Gastroenterology & hepatology, vol. 23, no. 4, 2026, pp. 331-354.
PMID
41286030 ↗
Abstract 한글 요약
Regulated cell death is a hallmark of inflammatory liver disease, and its intensity influences disease progression and severity. However, it is now clear that the form of cell death could also have an important role. In addition to apoptosis, various forms of regulated necrosis are increasingly reported to contribute to inflammatory liver disease due to their lytic nature. In this Review, we discuss the key regulatory molecules that govern regulated necrosis pathways and summarize our current understanding of the involvement of necroptosis, pyroptosis and ferroptosis in liver injury in preclinical murine models of acute and chronic liver disease and liver cancer development. Furthermore, we highlight the existing controversies and knowledge gaps regarding the relevance of these cell death modalities in hepatocytes and non-hepatocytic liver cells as well as the emerging mechanisms controlling these pathways. Finally, we discuss efforts to specifically modulate these regulated cell death pathways in liver disease and hepatocarcinogenesis in the attempt to prevent liver disease progression or to elicit more potent antitumour immune responses. Outstanding issues and methodological advances that will help to translate preclinical findings into therapeutic applications are also presented.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.